2019

• Hansra, G., Popov, G., Banaczek, P., Vogiatzis, M., Jegathees, T., Goldbury, C., Cullen, K. (2019). The neuritic plaque in Alzheimer's disease: perivascular degeneration of neuronal processes. Neurobiology of Aging, 82, 88-101. [More Information]

2018

• El Massri, N., Cullen, K., Stefani, S., Moro, C., Torres, N., Benabid, A., Mitrofanis, J. (2018). Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatum. Experimental Brain Research, 236(4), 955-961. [More Information]

2017

• Moro, C., Torres, N., Arvanitakis, K., Cullen, K., Chabrol, C., Agay, D., Darlot, F., Benabid, A., Mitrofanis, J. (2017). No evidence for toxicity after long-term photobiomodulation in normal non-human primates. Experimental Brain Research, 235(10), 3081-3092. [More Information]

2015

• Mathews, M., Murray, A., Wijesinghe, R., Cullen, K., Tung, V., Camp, A. (2015). Efferent Vestibular Neurons Show Homogenous Discharge Output But Heterogeneous Synaptic Input Profile In Vitro. PloS One, 10(9), 1-21. [More Information]

2014

• Rahman, T., Davies, D., Tannenberg, R., Fok, S., Shepherd, C., Dodd, P., Cullen, K., Goldsbury, C. (2014). Cofilin rods and aggregates concur with tau pathology and the development of alzheimer's disease. Journal of Alzheimer's Disease, 42(4), 1443-1460. [More Information]

2013

• Wu, W., Nicolazzo, J., Wen, L., Chung, R., Stankovic, R., Bao, B., Lim, C., Brew, B., Cullen, K., Guillemin, G. (2013). Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain. PloS One, 8(4), 1-11. [More Information]

2010

• Romo, P., Madigan, M., Provis, J., Cullen, K. (2010). Differential effects of TGF-Beta and FGF-2 on in vitro proliferation and migration of primate retinal endothelial and Muller cells. Acta Ophthalmologica, 89(3), 1-6. [More Information]
• Gregory-Roberts, E., Naismith, S., Cullen, K., Hickie, I. (2010). Electroconvulsive therapy-induced persistent retrograde amnesia: Could it be minimised by ketamine or other pharmacological approaches? Journal of Affective Disorders, 126(1 - Feb), 39-45. [More Information]
• Chen, Y., Stankovic, R., Cullen, K., Meininger, V., Garner, B., Coggan, S., Grant, R., Brew, B., Guillemin, G. (2010). The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis. Neurotoxicity Research, 18(2), 132-142. [More Information]

2009

• Whiteman, I., Gervasio, O., Cullen, K., Guillemin, G., Jeong, E., Witting, P., Antao, S., Minamide, L., Bamburg, J., Goldsbury, C. (2009). Activated actin-depolymerizing factor/cofilin sequesters phosphorylated microtubule-associated protein during the assembly of alzheimer-like neuritic cytoskeletal striations. Journal of Neuroscience, 29(41), 12994-13005. [More Information]
• Buljan, V., Ivanova, E., Cullen, K. (2009). How calcium controls microtubule anisotropic phase formation in the presence of microtubule-associated proteins in vitro. Biochemical and Biophysical Research Communications, 381(2), 224-228. [More Information]
• Rahman, A., Ting, K., Cullen, K., Braidy, N., Brew, B., Guillemin, G. (2009). The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PloS One, 4(7), e6344 - 1-e6344 - 15. [More Information]

2007

• Guillemin, G., Cullen, K., Lim, C., Smythe, G., Garner, B., Kapoor, V., Takikawa, O., Brew, B. (2007). Characterization of the kynurenine pathway in primary human neurons. Journal of Neuroscience, 27(47), 12884-12892. [More Information]
• Guillemin, G., Brew, B., Noonan, C., Knight, T., Smythe, G., Cullen, K. (2007). Mass spectrometric detection of quinolinic acid in microdissected Alzheimer disease plaques. International Congress Series, 1304, 404-408. [More Information]

2006

• Hardy, J., Cullen, K. (2006). Amyloid at the blood vessel wall. Nature Medicine, 12(7), 756-7. [More Information]
• Cullen, K., Kócsi, Z., Stone, J. (2006). Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages. Neurobiology of Aging, 27(12), 1786-1796. [More Information]

2005

• Guillemin, G., Brew, B., Noonan, C., Takikawa, O., Cullen, K. (2005). Audiologists' attitudes to cochlear implants. Neuropathology and Applied Neurobiology, 31, 395-404.
• Guillemin, G., Brew, B., Noonan, C., Takikawa, O., Cullen, K. (2005). Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathology and Applied Neurobiology, 31(4), 395-404. [More Information]
• Cullen, K., Kocsi, Z., Stone, J. (2005). Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. Journal of Cerebral Blood Flow and Metabolism, 25(12), 1656-1667. [More Information]
• Stankovic, R., Shingde, M., Cullen, K. (2005). The experimental toxicology of metallic mercury on the murine peripheral motor system: a novel method of assessing axon calibre spectra using the phrenic nerve. Journal of Neuroscience Methods, 147(2), 114-125. [More Information]